| Active principles | Rating | Bibliogr. | Expand |
---|
1 | RNA, Viral | 100 | + | |
2 | DNA, Viral | 71 | + | |
3 | Antibodies, Viral | 69 | + | |
4 | SAIDS Vaccines | 61 | + | |
5 | Viral Vaccines | 55 | + | |
6 | Pyrrolidinones | 46 | + | |
7 | Antibodies, Neutralizing | 45 | + | |
8 | HIV Core Protein p24 | 44 | + | |
9 | Interferon-alpha | 44 | + | |
10 | Gene Products, env | 40 | + | |
11 | Zidovudine | 40 | + | |
12 | Gene Products, gag | 36 | + | |
13 | HIV Antibodies | 36 | + | |
14 | Organophosphonates | 35 | + | |
15 | Adenine | 34 | + | |
16 | Vaccines, Attenuated | 33 | + | |
17 | Fusion Proteins, gag-pol | 33 | + | |
18 | Ganciclovir | 32 | + | |
19 | Viral Envelope Proteins | 31 | + | |
20 | AIDS Vaccines | 31 | + | |
21 | Alanine Transaminase | 29 | + | |
22 | DNA, Circular | 29 | + | |
23 | Ribavirin | 29 | + | |
24 | Recombinant Proteins | 27 | + | |
25 | Interferons | 26 | + | |
26 | Lamivudine | 25 | + | |
27 | Viral Core Proteins | 25 | + | |
28 | Vaccines, DNA | 24 | + | |
29 | Taq Polymerase | 24 | + | |
30 | Indinavir | 22 | + | |
31 | Stavudine | 21 | + | |
32 | Didanosine | 21 | + | |
33 | gag Gene Products, Human Immunodeficiency Virus | 21 | + | |
34 | Hepatitis C Antibodies | 21 | + | |
35 | HIV Envelope Protein gp41 | 21 | + | |
36 | Polyethylene Glycols | 20 | + | |
37 | Vaccines, Synthetic | 20 | + | |
38 | Foscarnet | 19 | + | |
39 | Retroviridae Proteins | 19 | + | |
40 | Organophosphorus Compounds | 18 | + | |
41 | Gene Products, pol | 18 | + | |
42 | DNA Primers | 18 | + | |
43 | Receptors, CCR5 | 18 | + | |
44 | Benzoxazines | 17 | + | |
45 | Viral Matrix Proteins | 16 | + | |
46 | HIV Reverse Transcriptase | 16 | + | |
47 | Interferon Type I | 15 | + | |
48 | Dengue Vaccines | 15 | + | |
49 | Programmed Cell Death 1 Receptor | 15 | + | |
50 | Hepatitis Antibodies | 15 | + | |
51 | Zalcitabine | 15 | + | |
52 | Retroviridae Proteins, Oncogenic | 15 | + | |
53 | RNA-Directed DNA Polymerase | 14 | + | |
54 | Gene Products, rev | 14 | + | |
55 | Interferon-gamma | 14 | + | |
56 | Viral Nonstructural Proteins | 14 | + | |
57 | Viral Proteins | 13 | + | |
58 | Oxazines | 13 | + | |
59 | HIV Envelope Protein gp120 | 13 | + | |
60 | Antigens, CD4 | 13 | + | |
61 | West Nile Virus Vaccines | 13 | + | |
62 | Antigens, CD14 | 12 | + | |
63 | Pyrimidinones | 12 | + | |
64 | Vaccines, Subunit | 12 | + | |
65 | Phosphoproteins | 12 | + | |
66 | HIV Integrase | 11 | + | |
67 | Acyclovir | 11 | + | |
68 | Ritonavir | 11 | + | |
69 | Receptors, CXCR4 | 11 | + | |
70 | Vaccines, Inactivated | 11 | + | |
71 | Lopinavir | 10 | + | |
72 | Immunoglobulin G | 10 | + | |
73 | Nucleosides | 10 | + | |
74 | Arabinofuranosyluracil | 10 | + | |
75 | Nevirapine | 10 | + | |
76 | Antigens, CD45 | 9 | + | |
77 | Immunoglobulin M | 9 | + | |
78 | DNA-Directed DNA Polymerase | 9 | + | |
79 | Guanine | 8 | + | |
80 | Interleukin-2 | 8 | + | |
81 | Interleukins | 8 | + | |
82 | Cytokines | 8 | + | |
83 | Immunoglobulins, Intravenous | 8 | + | |
84 | Immunoglobulins | 7 | + | |
85 | Peptide Fragments | 7 | + | |
86 | Hepatitis B Antibodies | 7 | + | |
87 | Aspartate Aminotransferases | 7 | + | |
88 | Antibodies, Monoclonal | 6 | + | |
89 | Recombinant Fusion Proteins | 6 | + | |
90 | Interleukin-10 | 5 | + | |
91 | Mycophenolic Acid | 4 | + | |